Skip to Main Content

Paper Details

Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer's disease biomarkers.
Cell Rep Med
2
2023
AD, Alzheimer's disease, CSF, cerebrospinal, patients
Author NameAffiliation
Adam L BoxerWeill Institute for Neuroscience, University of California san francisco
Hanno SteenBoston Children's Hospital, Harvard Medical School
Hanno SteenBoston Children's Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2